HELLP-syndrome as a life-threatening condition: current clinical considerations

HELLP-syndrome is an extremely serious complication of pregnancy with a high risk of adverse perinatal and maternal outcomes. Aim: to study the clinical course, maternal and perinatal complications in pregnant women with HELLP-syndrome. Materials and methods. We conducted a retrospective study on clinical records of 28 births by women with HELLP-syndrome and 35 women with severe preeclampsia (PE) without HELLP-syndrome manifestations. The diagnostic criteria of the HELLP-syndrome in patients with severe РЕ were based on the symptoms of intravascular hemolysis typically manifested in arterial hypertension, proteinuria, and generalized edema. Results. The classical three symptoms of HELLP-syndrome were noted only in 64.2 % of cases, and the mono-symptomatic course - in 35.7 % of cases. The total triad of HELLP-syndrome (hemolysis, thrombocytopenia, elevation of hepatic enzymes) was recorded in 42.8 % of cases. The most common form was the typical HELLP-syndrome, then - the ELLP-syndrome (elevation of liver enzymes and thrombocytopenia) - 57.2 % of cases; an isolated elevation of hepatic enzymes in severe PE was found in 53.5 % of cases, thrombocytopenia in severe PE - in 64.2 % of cases. A high incidence of adverse perinatal outcomes was also found: premature births (64.2 %) and antenatal fetal death (21.4 %). Conclusion. In the above clinical situations, the diagnostic judgement should be pointed towards the HELLP-syndrome; accordingly, the adequate obstetric management should be initiated to prevent the development of life-threatening complications in both the mother and the fetus.

1. Makatsariya A.D., Chervenak F.A., Bitsadze V.O. Pregnancy of high risk. [Beremennost' vysokogo riska]. Moskva: MIA, 2015. 920 s. (In Russ.).

2. Aloizos S., Seretis C. Liakos N. et al. HELLP-syndrome: understanding and management of a pregnancy-specific disease. J Obstet Gynaecol. 2013;33(4):331-7.

3. Fedyunina I.A. Fetoplacental complex and perinatal outcomes in pregnant women with impaired hepatic function. [Sostoyanie fetoplacentarnogo kompleksa i perinatal'nye iskhody u beremennyh s narusheniyami funkcii pecheni]. Avtoref. dis. kand. med. nauk. Moskva, 2018. 24 s. (In Russ.).

4. Makatsariya A.D., Bitsadze V.O., Khizroeva D.X., Akinshina S.B. Thrombotic microangiopathies in obstetric practice. [Tromboticheskie mikroangiopatii v akusherskoj praktike]. Moskva: GEOTAR-Media, 2017. 304 s. (In Russ.).

5. O'Brien J.M., Barton J.R. Controversies with the diagnosis and management of HELLP-syndrome. Clin Obstet Gynecol. 2005;48(2):460-77.

6. Hypertensive disorders during pregnancy, during childbirth and the postpartum period. Preeclampsia. Eclampsia. Clinical recommendations (protocol of treatment). Russian Society of Obstetricians and Gynecologists. [Gipertenzivnye rasstrojstva vo vremya beremennosti, v rodah i poslerodovom periode. Preeklampsiya. Eklampsiya. Klinicheskie rekomendacii (protokol lecheniya). Rossijskoe obshchestvo akusherov-ginekologov]. Utv. MZ RF 16 maya 2016 (Pis'mo MZ RF № 15-4/10/2-3483). Moskva, 2016. 40 s. (In Russ.). Accessed: http://www.rokb.ru/sites/default/files/pictures/gipertenzivnye_rasstroystva_vo_vremya_beremennosti_v_rodah_i_poslerodovom_periode._preeklampsiya._eklampsiya.pdf.

7. Audibert F., Friedman S.A., Frangieh A.Y., Sibai B.M. Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol. 1996;175(2):460-4.

8. Committee Opinion No 671: Perinatal risks associated with assisted reproductive technology. American College of Obstetricians and Gynecologists’ Committee on Obstetric Practice, Committee on Genetics, U.S. Food and Drug Administration. Obstet Gynecol. 2016;128(3):e61-8. DOI: 10.1097/AOG.0000000000001643.

9. Watanabe N., Fujiwara T., Suzuki T. et al. Is in vitro fertilization associated with preeclampsia? A propensity score matched study. BMC Pregnancy Childbirth. 2014;14:69. DOI: 10.1186/1471-2393-14-69.

10. Dizon-Townson D., Miller C., Sibai B. et al. The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus. Obstet Gynecol. 2005;106(3):517-24.

11. Said J.M., Higgins J.R., Moses E.K. et al. Inherited thrombophilia polymorphisms and pregnancy outcomes in nulliparous women. Obstet Gynecol. 2010;115(1):5-13.

12. Milne F., Redman C., Walker J. et al. The pre-eclampsia community guideline (PRECOG): how to screen for and detect onset of pre-eclampsia in the community. BMJ. 2005;330(7491):576-80.

13. Le Fevre M.L. U.S. Preventive Services Task Force Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;161(11):819-26.

14. Sibai B.M. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol. 2004;103(5 Pt 1):981-91.

15. Barton J.R., Riely C.A., Adamec Т.А. et al. Hepatic histopathologic condition does not correlate with laboratory abnormalities in HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count. Am J Obstet Gynecol. 1992;167(6):1538-43.

16. Makatsariya A.D., Bitsadze V.O., Khizroeva J.Kh. HELLP-syndrome. [HELLP-sindrom]. Akusherstvo, ginekologiya ireprodukciya. 2014;8(2):61-8. (In Russ.).

17. Altamura C., Vasapollo B., Tibuzzi F. et al. Postpartum cerebellar infarction and haemolysis, elevated liver enzymes, low platelet (HELLP) syndrome. ZNeurolSci. 2005;26(1):40-2.